Furthermore, targeting cDC1s via CLEC9A neutralizing antibodies effectively inhibited the expansion of AAA in mice, reinforcing the notion that CD8+ T cells are activated by cDC1s to promote AAA progression. Here, CLEC9A is linked to triple-A syndrome.